Clinical Evaluation Gastrointestinal Motility With PillCam
Clinical Evaluation of Endoscopic Video Capsule for Investigation of Small Intestine Transit Time and Intestinal Pathology in Critically Ill Patients
1 other identifier
observational
16
1 country
1
Brief Summary
The purpose of this study is to evaluate the clinical usefulness of a video camera pill (PillCam) in assessing intestinal function in the small intestines of patients. It is believed that the condition of the subjects digestive system can have a large impact on their overall physical health. Therefore, the investigators would like to assess whether using the pill device helps to determine any functional problems in patients in the ICU. The investigators are studying ICU patients because any change in their condition can have a large impact on their recovery. The same device will be used in healthy subjects scheduled for elective ambulatory surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started May 2006
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2008
CompletedFirst Submitted
Initial submission to the registry
July 6, 2010
CompletedFirst Posted
Study publicly available on registry
July 8, 2010
CompletedApril 13, 2017
April 1, 2017
1.5 years
July 6, 2010
April 11, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
small bowel transit times
Small bowel transit time was calculated by measuring the difference between the start-time (i.e., placement of the capsule in the duodenum) and end-time (i.e., capsule enters the cecum). Examination of the differences between subsequent images indicates the amount of capsule movement and is proportional to the instant velocity ("motility") of the capsule
8 hours
Secondary Outcomes (1)
visualization
8 hours
Study Arms (2)
Critically ill
Critically ill subjects were intubated, mechanically ventilated and sedated
Ambulatory Group
Subjects were scheduled for an outpatient procedure but were otherwise healthy
Interventions
Within four days of hospital admission, qualifying critically ill patients were assigned to the study and received a gastro-jejunal tube and one PillCam video telemetry capsule (Given Imaging Ltd., Yoqneam, Israel). In each critical care patient, placement of the video capsule was coupled with the placement of the medically necessary feeding tube. A flexible endoscope was inserted into the patient's mouth, and then advanced into the esophagus, stomach, and upper small intestine. The capsule was placed into a capsule delivery device and released into the distal duodenum after it had passed beyond the sight of the scope; a wire was placed to facilitate passage of the feeding tube. An abdominal X-ray was obtained to confirm feeding tube tip placement.
Eligibility Criteria
Critically ill patients (i.e., all were intubated, mechanically ventilated and sedated) and healthy patients scheduled for an outpatient procedure.
You may qualify if:
- mild-to-moderate brain injury patients who suffered from traumatic or non-traumatic intracranial hemorrhage
- admitted to an intensive care unit (ICU)
- needed an enteral tube placed for feeding
- control (ambulatory) group consisted of outpatients with no history of major abdominal surgery
You may not qualify if:
- younger than 18 years
- suffered multiple injuries (especially abdominal trauma or inflammatory bowel disease)
- had a history of complicated or unknown abdominal surgery
- presented with clinical evidence of ileus or suspected obstruction
- Patients with a pacemaker
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Louisville Hospital
Louisville, Kentucky, 40202, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Stefan Rauch, MD
University of Louisville
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 6, 2010
First Posted
July 8, 2010
Study Start
May 1, 2006
Primary Completion
November 1, 2007
Study Completion
June 1, 2008
Last Updated
April 13, 2017
Record last verified: 2017-04